January 27, 2017
Sumitomo Dainippon Pharma said on January 26 that it has completed the acquisition of Tolero Pharmaceuticals, a US biotech startup specializing in cancer and hematologic disorders, which was announced in December. Through the deal, the Japanese drug maker obtained six...read more